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With the purpose of obtaining a biocompatible and microbiologically safe matrix that simultaneously could be used as wound dress-
ing material and as a controlled drug release system, membranes with different thickness and different contents in chitosan and hydroxy-
ethyl methacrylate (HEMA) have been prepared by c irradiation from a 60Co source. Antibiotic release experiments were performed
before or after irradiation over amoxicillin loaded chitosan/pHEMA membranes in physiological saline solution, and monitored by
UV–Vis spectrometry.
Results point out a fast amoxicillin release with similar release profile in all studied membranes. The amount of released drug was
shown to be dependent on membranes network crosslinking due composition, radiation and membrane thickness.
 2007 Elsevier B.V. All rights reserved.
PACS: 81.05.Lg; 82.35.Jk; 82.35.Pq; 82.50.Kx
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Most drugs can be administered by a variety of routes,
broadly defined as local and systemic. Drugs administered
systemically are absorbed into blood stream and distrib-
uted throughout the host patient via the circulatory system,
which can result in microbiological resistance [1]. Site-
specific release systems limit the adverse effects of systemic
administration and offer distinctive advantages over the
classical methods of drug delivery. These include improve-
ment of delivery efficacy, reduced toxicity and improved
patient compliance and convenience [1,2].
In the specific case of wound dressing, the possibility of
simultaneous rapid and proper healing of the damage0168-583X/$ - see front matter  2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.nimb.2007.09.013
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E-mail address: casimiro@itn.pt (M.H. Casimiro).tissues with local drug treatment would be an important
advantage. Polysaccharides, like chitosan and its deriva-
tives, have been considered to be advantageous in their
application as a wound dressing material since they may,
by themselves, actively participate in the process of wound
healing [3–5].
Chitosan [poly-b(1-4)-D-glucosamine] is a cationic poly-
saccharide of natural origin that is obtained by alkaline
deacetylation of chitin, the principal exoskeleton compo-
nent in crustaceans. Due to an unusual combination of
properties such as non-toxicity, biocompatibility, biode-
gradability, bioactivity, acceleration of wound healing, fat
biding capacity, etc., biomedical and environmental
applications of chitosan and its chemically modified struc-
tures have been reported [2,3,6–10].
Among possible physical–chemical modifications need
to adequate the polymer to each application, graft
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revealed itself a very attractive technique since it could
enable a wide variety of molecular designs to afford novel
types of tailored hybrid materials [11–14].
In previous work [11,12] we have evaluated the effect of
various synthesis conditions on some physical, chemical
and microbiological properties of chitosan/poly(hydroxy-
ethyl methacrylate) copolymers obtained by c irradiation
from a 60Co source. pHEMA is a synthetic hydrogel which
possesses high mechanical strength and biocompatibility
[15]. Since natural macromolecular materials such as chito-
san are usually mechanically weak and often difficult to pro-
cess as membranes, the conjunction of these two
components may result in a new matrix that combines the
useful properties of both polymers. The purpose of this
study has been to assess the possibilities of obtaining chito-
san/pHEMA membranes that would maintain the wound
dressing ability of chitosan backbone and simultaneously
could be used as a biocompatible and microbiologically safe
dermal matrix for controlled drug release. The drug in use
was amoxicillin, which is a moderate-spectrum antibiotic
(active against a wide range of gram-positive and a limited
range of gram-negative organisms) widely used for the
treatment of skin infections among others infections.
The work was divided in two parts and, here, only drug
release experimental data are presented. In vitro haemolysis
tests and extensive microbiological experiments have been
submitted to appreciation for publication elsewhere.
2. Experimental
2.1. Materials
Chitosan medium molecular weight (1.9 · 105–3.1 ·
105 Da) 75–85% deacetylated was obtained from Aldrich
Chemical Company, Inc., Milwaukee, USA. This was trit-
urated (u < 500 lm) and dried under vacuum at 313 K.
Hydroxyethyl methacrylate (HEMA), stabilised, 98%,
was obtained from ACROS Organics, Belgium, and used
as received. All other chemical used were of analytical
grade and used as received.
2.2. Preparation of chitosan/pHEMA membranes
The membranes preparation was achieved by mixing dif-
ferent chitosan solutions (1%, 3% and 5%w/V of chitosan in
acetic acid 1%) with HEMAmonomer (1%, 3% and 5% V/V
of the finalmixture). The bubble-free aqueous solutionswere
poured on a clean glass plate in a dust-free atmosphere and
allowed to dry at room temperature. The membranes thus
formed were washed with NaOH 1% and then with distilled
water and carefully peeled off from the glass plate.
Membranes were dried to constant weight in vacuum at
313 K and then immersed for 2 h in amoxicillin solution
(100 mg/ml in saline solution (NaCl 0.9% w/V)). Depen-
dent on membranes composition the thickness range of
swollen samples varied within 50 and 420 lm.Afterwards membranes were blotted free of surface drug
solution with a filter paper, sealed in Amilon polyamide
bags under nitrogen atmosphere and c irradiated at
0.6 kGy h1 (4 kGy) using a 60Co gamma source at room
temperature.
The low dose rate and absorbed dose values which mem-
branes were exposed to, were chosen based on the intrinsic
behaviour of the system in study versus gamma radiation
(chitosan is a degradative type polymer) and on previous
membranes microbiological experiments (being naturally
low contaminate, is expected that chitosan based mem-
branes in study would need very low doses to assure the
standard microbiological safety) [12]. Moreover, and in
spite of other studies have reported the feasibility of
gamma radiation (25 kGy) as a sterilization method of
amoxicillin [16], lower radiation doses would minimize
eventual induced degradation products as well as adverse
side effects on physical and chemical matrix properties
[11,17].
2.3. Characterisation of chitosan/pHEMA membranes –
Antibiotic release studies
Antibiotic release experiments were divided in irradiated
and non-irradiated groups and performed over amoxicillin
loaded membranes with different contents of chitosan/
HEMA and different thickness.
Each membrane drug loaded was immersed in 100 ml of
physiological saline solution at 310 K with slight orbital
stirring. The released amoxicillin was monitored at
276 nm on a UV–Vis–NIR spectrophotometer (Cary 5G,
Varian, Switzerland), until no further changes of absor-
bance values were observed. These absorbance measure-
ments were converted into amoxicillin concentrations
using an adequate amoxicillin calibration curve and the
total amount of released drug was calculated using three
replicates for each membrane composition/thickness. To
determine the amount of amoxicillin initially loaded, mem-
branes were weight prior (in dried state) and after drug
loaded procedure (in swollen state).
3. Results and discussion
In order to investigate the feasibility of using the pre-
pared membranes as a matrix for controlled drug release,
amoxicillin (as a model drug) was loaded into chitosan/
pHEMA.
Fig. 1 shows the release profiles in saline solution of
amoxicillin from chitosan/pHEMA irradiated and non-
irradiated membranes with different content in chitosan
(1% and 3%) and HEMA 1% (mean ± SD from three inde-
pendent experiments). Swollen membranes presented a
thickness of 150 and 180 lm respectively for chitosan 1%
and chitosan 3% content.
Results indicate that both formulations present similar
release profiles (contrary to the initially expected), with
an initial burst effect that may be attributed to the diffusion
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Fig. 1. Amoxicillin release profiles in saline solution at 310 K of non-
irradiated and c-irradiated chitosan/pHEMA membranes (CxHy – x indi-
cates the percentage of chitosan and y the percentage of HEMA).
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Fig. 2. (a) Drug absorption and drug release behaviour of different c-
irradiated chitosan based membranes. (b) Drug absorption and drug
release behaviour of different c-irradiated chitosan/pHEMA membranes –
Interception of curves tendency fitting.
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Fig. 3. Maximum amoxicillin released of c-irradiated chitosan/pHEMA
membranes.
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towards the surface matrix as reported by other authors
with different polymeric matrix [18]. Furthermore, this
drug release behaviour is also extended to all prepared
membranes independently of composition and thickness.
In this way, all formulations present a fast release of
amoxicillin that result in a maximum availability of the
drug in 1–2 h, fact that may have to be with membranes
formulation used (ratio of chitosan/pHEMA does not vary
significantly in composition terms, only in membranes
density).
From Fig. 1 is still possible to observe a slight drug
release fall after c irradiation result of an increase in net-
work crosslinking density (as suggested by previous scan-
ning electron microscopy due to the reduction in porous
size network [12]), and consequently a higher amount of
entrapped drug.
Moreover, as represented membranes present similar
thickness values it would be expected to tailor drug release
rate by changing that feature. However it did not come to
be. Results show that for each membrane composition
studied, the convenient selection of membranes thickness
allows us to tailor drug absorbed/released amount (instead
of drug release rate) as can be seen in Fig. 2(a).
Fig. 2(a) exhibits the maximum drug absorption and
drug release (in mg of drug per membrane) of all different
c-irradiated chitosan based membranes obtained. It sug-
gests that maximum values of drug absorption/release are
essentially dependent on membranes chitosan content
given that chitosan 3% based membranes presents very
similar values when compared with chitosan 1% based
membranes. It seems that an increase in membranes
chitosan content leads to a shrinkage of the porous net-
work when irradiated and consequently to the diminution
of amoxicillin release efficiency after irradiation due drug
entrapment as mentioned before.
At the same time it can be seen that enlarging mem-
branes thickness enables higher drug absorption values
(in non-irradiated membranes), but induces minor drug
release amounts in irradiated ones due to the increasingnetwork crosslinking density as earlier mentioned.
Fig. 2(b) points out the behaviour just mentioned by exhib-
iting the curves tendency fitting of drug absorption/release
displayed data.
Drug release data can also be expressed in percentage as
shown in Fig. 3. Results let to anticipate an optimum mem-
brane thickness range for amoxicillin release efficiency after
irradiation. To determinate it, membranes composition,
drug absorption and drug release curves (mg/membrane)
have to be considered.
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In the present study attention has been paid to the
amoxicillin release kinetics of gamma irradiated chitosan/
pHEMA membranes. Results point out a fast amoxicillin
release with similar release profile in all studied membranes
contrary to the initially expected. According to obtained
data it appears to be that the amount of released drug is
dependent on membranes network crosslinking and in this
way the amount of released drug can be tailored according
to needs by selecting adequate composition and thickness.
Obtained results also suggest the existence of an optimum
membrane thickness range for amoxicillin release
efficiency.
However, if only wound dressing features are being con-
sidered it might come out a different optimum membrane
thickness, since the swelling properties are important to
mimic the skin’s moisture. As this study aim to obtain a
matrix that simultaneously could be used as wound dress-
ing material and as a controlled drug release system, partic-
ular attention should be done to membranes thickness once
it can shape both features response.Acknowledgements
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